BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization
- 28 August 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (17), 6953-6962
- https://doi.org/10.1158/0008-5472.can-08-0365
Abstract
BRCA1-associated protein-1 (BAP1), a deubiquitinating enzyme of unknown cellular function, is mutated in breast and lung cancers. In this study, we have shown for the first time that BAP1 has tumor suppressor activity in vivo by showing that BAP1 can suppress tumorigenicity of lung cancer cells in athymic nude mice. We show that BAP1 fulfills another criterion of a genuine tumor suppressor because cancer-associated BAP1 mutants are deficient in deubiquitinating activity. We show for the first time that one of the two predicted nuclear targeting motifs is required for nuclear localization of BAP1 and that a truncation mutant found in a lung cancer cell line results in BAP1 that fails to localize to the nucleus. Furthermore, we show that deubiquitinating activity and nuclear localization are both required for BAP1-mediated tumor suppression in nude mice. We show that BAP1 exerts its tumor suppressor functions by affecting the cell cycle, speeding the progression through the G1-S checkpoint, and inducing cell death via a process that has characteristics of both apoptosis and necrosis. Surprisingly, BAP1-mediated growth suppression is independent of wild-type BRCA1. Because deubiquitinating enzymes are components of the ubiquitin proteasome system, this pathway has emerged as an important target for anticancer drugs. The identification of the deubiquitinating enzyme BAP1 as a tumor suppressor may lead to further understanding of how the ubiquitin proteasome system contributes to cancer and aid in the identification of new targets for cancer therapy. [Cancer Res 2008;68(17):6953–62]Keywords
This publication has 29 references indexed in Scilit:
- Emerging roles of deubiquitinating enzymes in human cancerActa Pharmacologica Sinica, 2007
- Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in diseaseBriefings in Functional Genomics and Proteomics, 2007
- Rules for Nuclear Localization Sequence Recognition by Karyopherinβ2Cell, 2006
- BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIPGenes & Development, 2006
- Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB SignalingCell, 2006
- The Ubiquitin-Proteasome Pathway and Its Role in CancerJournal of Clinical Oncology, 2005
- Dermal papilla-induced hair differentiation of adult epithelial stem cells from human skinPhysiological Genomics, 2004
- Ubiquitin and breast cancerOncogene, 2004
- Roles of Ubiquitinylation in Proteolysis and Cellular RegulationAnnual Review of Nutrition, 1995
- Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3‐3p21.3 in sporadic breast‐cancer developmentInternational Journal of Cancer, 1994